M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.497 PLN 0.81% Market Closed
Market Cap: 33.8m PLN

Intrinsic Value

The intrinsic value of one MDB stock under the Base Case scenario is 0.016 PLN. Compared to the current market price of 0.497 PLN, Medicofarma Biotech SA is Overvalued by 97%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MDB Intrinsic Value
0.016 PLN
Overvaluation 97%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
Medicofarma Biotech SA

What is Valuation History?
Ask AI Assistant
What other research platforms think about MDB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MDB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Medicofarma Biotech SA.

Explain Valuation
Compare MDB to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about MDB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medicofarma Biotech SA

Current Assets 4m
Receivables 600k
Other Current Assets 3.4m
Non-Current Assets 10m
PP&E 9.8m
Intangibles 70k
Other Non-Current Assets 160k
Current Liabilities 4.7m
Accounts Payable 3.3m
Accrued Liabilities 1.3m
Other Current Liabilities 80k
Non-Current Liabilities 3.9m
Other Non-Current Liabilities 3.9m
Efficiency

Free Cash Flow Analysis
Medicofarma Biotech SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medicofarma Biotech SA

Revenue
279.3k PLN
Cost of Revenue
-178.2k PLN
Gross Profit
101.1k PLN
Operating Expenses
-3.1m PLN
Operating Income
-3m PLN
Other Expenses
-235k PLN
Net Income
-3.2m PLN
Fundamental Scores

MDB Profitability Score
Profitability Due Diligence

Medicofarma Biotech SA's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Sustainable 3Y Average Gross Margin
Healthy Gross Margin
Gross Margin is Increasing
Declining Net Margin
17/100
Profitability
Score

Medicofarma Biotech SA's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

MDB Solvency Score
Solvency Due Diligence

Medicofarma Biotech SA's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
48/100
Solvency
Score

Medicofarma Biotech SA's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDB Price Targets Summary
Medicofarma Biotech SA

There are no price targets for MDB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Medicofarma Biotech SA
does not pay dividends
Shareholder Yield

Current shareholder yield for MDB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one MDB stock?

The intrinsic value of one MDB stock under the Base Case scenario is 0.016 PLN.

Is MDB stock undervalued or overvalued?

Compared to the current market price of 0.497 PLN, Medicofarma Biotech SA is Overvalued by 97%.

Back to Top